Log In
BCIQ
Print this Print this
 

HPV-SLP (ISA-HPV-01, ISA101, SLP-HPV-01)

  Manage Alerts
Collapse Summary General Information
Company ISA Pharmaceuticals B.V.
DescriptionImmunotherapeutic consisting of 4 synthetic long peptides from E6 transforming protein (HpV16gp1) and 9 synthetic long peptides from E7 transforming protein (HpV16gp2) of the HPV type 16 virus
Molecular Target E6 transforming protein (Human papillomavirus-16) (HpV16gp1) ; E7 transforming protein (Human papillomavirus-16) (HpV16gp2)
Mechanism of ActionImmunotherapy
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/03/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today